Novartis Meningococcal ACWY Conjugate Vaccine
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Novartis Meningococcal ACWY Conjugate Vaccine, covering 2013-11-07 to 2015-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Children Aged 12-59 Months. [Phase 2]